4.3 Article

Resveratrol Enhances the Radiosensitivity by Inducing DNA Damage and Antitumor Immunity in a Glioblastoma Rat Model under 3 T MRI Monitoring

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer

Romulo S. Cavalcante et al.

Summary: The study developed a methotrexate-loaded nanocarrier combined with a PD-L1 antibody to modulate the immune response in breast cancer TME, leading to reduction of primary tumor size and metastases.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Biotechnology & Applied Microbiology

Analysis of chromosomal aberrations and γH2A.X foci to identify radiation-sensitive ataxia-telangiectasia patients

Martin Bucher et al.

Summary: AT patients exhibit increased radiation sensitivity and chromosomal instability. Analysis of gamma H2A.X foci and chromosomal aberrations can serve as potential biomarkers for radiation sensitivity in AT patients, with complex aberrations and dicentric chromosomes showing promise in this regard. However, there are individual differences in response among patients.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2021)

Article Biochemistry & Molecular Biology

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition

Kevin Litchfield et al.

Summary: Checkpoint inhibitors (CPIs) enhance adaptive immunity, with clonal tumor mutation burden (TMB) identified as the strongest predictor of CPI response. Dinucleotide variants may serve as a source of immunogenic epitopes, while copy-number alterations and HLA evolutionary divergence lack pan-cancer significance.
Article Biochemistry & Molecular Biology

Efficient Stable Cell Line Generation of Survivin as an In Vitro Model for Specific Functional Analysis in Apoptosis and Drug Screening

Rashid Houshdarpour et al.

Summary: This study focused on identifying proteins that reduce the effectiveness of cancer treatment, with survivin showing promise in regulating cell death and survival. Overexpression of survivin in HEK cells led to increased resistance to apoptotic stimuli and decreased caspase activity. Furthermore, survivin decreased ROS levels, increased ATP content, and reduced apoptosis rates, suggesting its potential for cancer treatment applications.

MOLECULAR BIOTECHNOLOGY (2021)

Review Oncology

Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review

AmirAhmad Arabzadeh et al.

Summary: Glioblastoma is an aggressive type of brain tumor with resistance to conventional therapies. Resveratrol, a natural polyphenolic compound, has shown to have anti-tumoral effects by regulating various cellular pathways such as cell cycle progression, autophagy, and apoptosis. Studies have also explored the potential of using resveratrol in combination with radiation therapy and chemotherapy for glioblastoma treatment.

CANCER CELL INTERNATIONAL (2021)

Review Immunology

Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells

Qi Mu et al.

Summary: Overcoming tumor resistance to therapy requires in-depth knowledge of intercellular communications within the tumor microenvironment. Various immune cells and non-immune cells in the TME interact with cancer cells, playing a key role in tumor growth or inhibition. Resveratrol has shown potential in modulating these interactions to enhance anti-tumor immunity and reduce cancer cell resistance.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Engineering, Biomedical

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Rohit K. Sharma et al.

Summary: Glioblastoma (GBM) is the most malignant form of primary brain tumors, with an urgent need for novel treatment modalities. Non-coding RNAs (ncRNAs), particularly long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play crucial roles in GBM and are potential therapeutic targets. Nanoparticles (NPs) show promise in delivering ncRNA-based therapies, but overcoming the blood-brain barrier (BBB) remains a significant challenge in treating brain-related conditions like GBM.

FRONTIERS IN MEDICAL TECHNOLOGY (2021)

Article Oncology

Msi1 inhibits cervical cancer cell apoptosis by downregulating BAK through AKT signaling

Xian Liu et al.

Summary: Msi1 regulates cervical cancer cell apoptosis by inhibiting PTEN and activating AKT signaling, leading to the downregulation of BAK.

JOURNAL OF CANCER (2021)

Review Oncology

Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization

Keywan Mortezaee et al.

CURRENT CANCER DRUG TARGETS (2020)

Article Cell Biology

Doublecortin undergo nucleocytoplasmic transport via the RanGTPase signaling to promote glioma progression

Abiola Abdulrahman Ayanlaja et al.

CELL COMMUNICATION AND SIGNALING (2020)

Article Oncology

ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer

Zhi-Hua Liu et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Cardiac & Cardiovascular Systems

The protection effects of survivin in the cell model of CVB3-induced viral myocarditis

Rongzhou Wu et al.

HEART AND VESSELS (2020)

Article Medicine, Research & Experimental

Radiomic prediction models for the level of Ki-67 and p53 in glioma

Xiaojun Sun et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Biochemistry & Molecular Biology

Validation of Enhancing Effects of Curcumin on Radiotherapy with F98/FGTGlioblastoma-Bearing Rat Model

Wei-Hsun Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cell Biology

Natural products and their derivatives: Promising modulators of tumor immunotherapy

Li-Juan Deng et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Immunology

The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives

Milad Ashrafizadeh et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Review Biology

A review, of traditional Chinese medicine for treatment of glioblastoma

Jinjing Wang et al.

BIOSCIENCE TRENDS (2019)

Review Immunology

Regulation and Function of the PD-L1 Checkpoint

Chong Sun et al.

IMMUNITY (2018)

Review Clinical Neurology

Translational gap in ongoing clinical trials for glioma

Alecia Florence Guishard et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2018)

Review Clinical Neurology

Advances in Radiotherapy for Glioblastoma

Justin Mann et al.

FRONTIERS IN NEUROLOGY (2018)

Editorial Material Pharmacology & Pharmacy

Is Resveratrol a Cancer Immunomodulatory Molecule?

Ly Quoc Trung et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Targeting glioma stem cells through combined BMI1 and EZH2 inhibition

Xun Jin et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model

Liang Chen et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2015)

Article Oncology

Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways

Meredith A. Morgan et al.

CLINICAL CANCER RESEARCH (2015)

Article Pharmacology & Pharmacy

Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo

Long Wang et al.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)

Review Pharmacology & Pharmacy

ATM and ATR as therapeutic targets in cancer

Anika Maria Weber et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Oncology

Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed

Takamitsu Hara et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Article Biochemistry & Molecular Biology

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7

S Shin et al.

BIOCHEMISTRY (2001)